Kelyniam Global, Inc. 是一家医疗器械制造公司,主要从事利用计算机辅助设计和计算机辅助制造先进医用级聚合物来生产定制假体。公司总部位于阿肯色州小石城。该公司于2008年4月3日首次公开募股(IPO)。公司利用计算机辅助设计和计算机辅助制造医用级聚合物来生产定制假体。其工程部门使用生物计算机辅助设计(CAD)和计算机辅助制造(CAM)技术,提供复制的颅骨植入物以替代受损的骨结构。其产品PEEK-Optima经过工程设计以实现生物相容性。利用患者的计算机断层扫描(CT)数据,该公司的3D BIO-CAD/CAM软件可将缺陷边缘的细节直接转移到植入物边缘。其应急计划ke24可在大约24小时内提供精确复制的、患者专用的颅骨植入物。公司通过独立分销商和销售代表在美国境内分销其产品。
KLYG stock price ended at $0.14 on 星期一, after rising 16.67%
On the latest trading day Feb 09, 2026, the stock price of KLYG rose by 16.67%, climbing from $0.13 to $0.14. During the session, the stock saw a volatility of 7.69%, with prices oscillating between a daily low of $0.13 and a high of $0.14. Notably, trading volume dropped by 8.9K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 10.4K shares were traded, equating to a market value of approximately $7.0M.